subscribeSubscribe
price-trendAsk Us
CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat

CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat
GLOBENEWSWIRE
21 Feb 2023
Share Share
AstraZeneca to acquire CinCor Pharma in nearly $2 billion deal

AstraZeneca to acquire CinCor Pharma in nearly $2 billion deal
PRESS RELEASE
10 Jan 2023
Share Share
CinCor`s hypertension drug loses halo after phase 2 fail

CinCor`s hypertension drug loses halo after phase 2 fail
James Waldron FIERCEBIOTECH
29 Nov 2022
Share Share
CinCor Pharma Announces Publication in the NEM of Phase 2 BrigHtn Data

CinCor Pharma Announces Publication in the NEM of Phase 2 BrigHtn Data
GLOBENEWSWIRE
07 Nov 2022
Share Share
CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat

CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat
GLOBENEWSWIRE
25 Oct 2022
Share Share
CinCor Pharma Announces Oral Presentation of Phase 1 Data for Baxdrostat

CinCor Pharma Announces Oral Presentation of Phase 1 Data for Baxdrostat
CINCOR
12 Oct 2022
Share Share
CinCor Announces Presentation of Phase 1 Clinical Data for Baxdrostat

CinCor Announces Presentation of Phase 1 Clinical Data for Baxdrostat
GLOBENEWSWIRE
22 Aug 2022
Share Share
CinCor raises $225M on back of positive PhII readout

CinCor raises $225M on back of positive PhII readout
Lei Lei Wu ENDPOINTS NEWS
11 Aug 2022
Share Share
CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial

CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial
PRESS RELEASE
26 Jul 2022
Share Share